New weekly shot aims to tackle diabetes and obesity together
Disease control
Recruiting now
This study tests a new medicine called GL0034, given as a weekly shot, for people with type 2 diabetes who are also overweight or obese. About 285 adults will receive either the study drug or a placebo for up to 48 weeks. The main goal is to see if GL0034 can lower blood sugar le…
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated May 01, 2026 15:57 UTC